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Transcriptional arrest triggers ubiquitylation of
RNA polymerase II (RNAPII). We mapped the
yeast RNAPII ubiquitylation sites and found
that they play an important role in elongation
and the DNA-damage response. One site lies
in a protein domain that is unordered in free
RNAPII, but ordered in the elongating form,
helping explain the preferential ubiquitylation
of this form. The other site is >125 A˚ngstroms
away, yet mutation of either site affects ubiq-
uitylation of the other, in vitro and in vivo. The
basis for this remarkable coupling was uncov-
ered: an Rsp5 (E3) dimer assembled on the
RNAPII C-terminal domain (CTD). The ubiquity-
lation sites bind Ubc5 (E2), which in turn binds
Rsp5 to allowmodification. Evidence for folding
of the CTD compatible with this mechanism
of communication between distant sites is pro-
vided. These data reveal the specificity and
mechanism of RNAPII ubiquitylation and dem-
onstrate that E2s can play a crucial role in
substrate recognition.
INTRODUCTION
Protein ubiquitylation has emerged as a crucial and com-
mon conduit for the regulation of cellular processes. Pro-
tein monoubiquitylation serves to alter the activity of the
target protein or to tag it for interaction with other factors.
In contrast, multiubiquitylation typically leads to degrada-
tion of the target protein by the proteasome (Varshavsky,
1997; Pickart, 2001). Ubiquitylation requires the coopera-
tion of three enzymes: E1 (ubiquitin-activating protein), E2
(ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase)
(Pickart, 2001). There is only one E1 in eukaryotic cells,
but several E2s and innumerable E3s. While the E1 merely
activates ubiquitin, the E2 and the E3 form a transientcomplex, which recognizes and ubiquitylates the protein
substrate. E2/E3 complexes of two main types exist (Ard-
ley and Robinson, 2005): those where the E3 recognizes
the substrate to allow ubiquitin transfer directly from the
E2 (E3s of the RING-finger/U-box families) and those
where the E3 both recognizes the substrate and ubiquity-
lates it. Here, ubiquitin transfer is from the E2 to the E3 and
then to the substrate (homologous to the E6-AP carboxyl
terminus [HECT] domain E3s). Interestingly, although
several examples of the effects and importance of ubiqui-
tylation have been reported, key questions about the
mechanism of protein ubiquitylation remain unanswered.
For example, the manner in which recognition of the sub-
strate and its site-specific ubiquitylation are connected is
poorly understood, and detailed examples of the reaction
mechanism of different E2-E3 pairs are relatively few. It
is generally believed that only the E3 recognizes and
positions the substrate for ubiquitylation. The substrate
binding sites of E3s are, however, typically quite far from
the site of actual ubiquitylation (the E3 active site). More-
over, in the few cases where structural data on an E2-E3
complex is available, the active site of the E2 and the ac-
tive site of the HECT E3 are also far apart (Huang et al.,
1999), necessitating substantial structural rearrange-
ments to occur during substrate recognition and catalysis
(Verdecia et al., 2003). A better understanding of the coop-
eration between E2 and E3 during catalysis is crucial to
understand protein ubiquitylation.
One interesting substrate for protein ubiquitylation is
RNAPII, which transcribes all protein-encoding genes in
eukaryotes (Boeger et al., 2005). Polyubiquitylation and
degradation of RNAPII was first thought to occur specifi-
cally in response to DNA damage (Bregman et al., 1996;
Ratner et al., 1998; Beaudenon et al., 1999), but recent ex-
periments have shown that RNAPII arrested during tran-
script elongation is generally prone to ubiquitylation and
degradation (Somesh et al., 2005). Thus, it has been sug-
gested that degradation of RNAPII is a ‘‘last resort,’’ used
to clear active genes of persistently arrested RNAPII elon-
gation complexes (Woudstra et al., 2002; Svejstrup, 2003;
Somesh et al., 2005). We recently reconstituted RNAPIICell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc. 57
Figure 1. RNAPII Ubiquitylation Sites and
the Effect of their Mutation
(A) In the upper panel, a sequence of identified
ubiquitin-linked Rpb1 peptides (single letter
code) is shown. In the lower panels, compari-
son of the yeast peptides with those of the
human homolog (alignment according to
Cramer et al. [2001]) is shown. The following
abbreviations are used: S.c., Saccharomyces
cerevisiae; H.s., Homo sapiens. Arrows indi-
cate potential ubiquitylation sites.
(B) Phenotypic consequences of mutating
K330 and/or K695 to arginine. Cells carrying
(URA3 CEN) plasmid-borne wt RBP1 were
transformed with (TRP1 CEN) plasmids
expressing wt or mutant Rpb1. Dilution series
were grown on yeast minimal medium (SD), or
5-fluoroorotic acid (5-FOA), respectively, for
2–4 days at 30C to evict the URA3 plasmid.
(C) Sensitivity of Rpb1 ubiquitylation-site mu-
tants to 6-azauracil (6-AU), compared to that
of cells lacking DST1 (encoding TFIIS).
(D) Viability of cells expressing the Rpb1 ubiqui-
tylation-site mutants was tested as described
in (B), but in a dst1 strain.
(E) Rpb1 ubiquitylation in response to tran-
scriptional arrest in wt, K330R, and K695R
cells. The upper panel shows awestern blot of RNAPII immunoprecipitations from the indicated cell types treated (+) or not treated () with 6-azauracil
(6-AU), probed with anti-ubiquitin antibodies. The lower panel shows Ponceau S stain of the membrane used for the western blot. Size markers are
indicated on the left and the identity of protein bands on the right.ubiquitylation in vitro with highly purified yeast ubiquityla-
tion factors and showed that the elongating RNAPII form is
a much better substrate than the free form (Somesh et al.,
2005). However, the explanation for this substrate dis-
crimination by highly purified proteins was not apparent.
The HECT E3 among the ubiquitylation factors, Rsp5,
binds RNAPII via the flexible C-terminal repeat domain
(CTD) of the Rpb1 subunit (Huibregtse et al., 1997). Inter-
estingly, although the CTD is absolutely required for
RNAPII ubiquitylation, Rsp5-mediated modification oc-
curs in the main body of the Rpb1 subunit (Peng et al.,
2003; Somesh et al., 2005). The importance for trans-
cription and the DNA-damage response of site-specific
RNAPII ubiquitylation has not been addressed. We have
now mapped sites of RNAII ubiquitylation to facilitate an
understanding of the role of such modification in vivo,
with the additional goal of understanding the mechanism
of RNAPII ubiquitylation. We discovered two distinct
Rpb1 ubiquitylation sites, K330 and K695. Mutation of
these sites has important functional consequences for
transcript elongation and the DNA-damage response. Re-
markably, although these sites are far apart (more than
125 A˚ngstroms), their modification is coordinated in vitro
as well as in vivo, suggesting that an E2/E3/RNAPII com-
plex is assembled that depends on not only the RNAPII
CTD but also on the Rpb1 ubiquitylation sites themselves.
We have indeed identified such a complex, revealing the
mechanistic basis for RNAPII ubiquitylation and also the
role of the CTD. We further show that, surprisingly, it is
the E2 (Ubc5) that recognizes the sites of modification.58 Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc.RESULTS
In order to map sites of RNAPII ubiquitylation, yeast
RNAPII was ubiquitylated in vitro by highly purified ubiqui-
tylation factors (Uba1, Ubc5, and Rsp5) and subjected to
mass spectrometric analysis. We recently reported that
this approach identified an ubiquitylated peptide contain-
ing Rpb1 K695 (Somesh et al., 2005), whichwas also inde-
pendently identified as a target of RNAPII ubiquitylation
in vivo (Peng et al., 2003). Our further analysis uncovered
another peptide, in which GG from the C terminus of ubiq-
uitin was linked to ‘‘ARLKGKEGR’’ of Rpb1. This indicated
that either K330 or K332 is also a target of ubiquitylation
(Figure 1A).
The RNAPII Ubiquitylation Sites Mapped In Vitro
Are Also Targeted In Vivo
The biological relevance of the mapped ubiquitylation
sites was first investigated by site-directed mutagenesis
and analysis in vivo. In our initial approach, K330 and
K332 were comutated, but subsequent experiments indi-
cated that the actual site of ubiquitylation is K330 (or at
least that if ubiquitylation also occurs at K332, it has no
functional consequence [Figure S1]). Independent muta-
tion of lysine 330, or lysine 695, to arginine did not result
in a growth phenotype under normal conditions. In con-
trast, concomitant mutation of both sites was lethal
(Figure 1B).
In order to investigate the role of the RNAPII ubiquityla-
tion sites in transcript elongation in vivo, the effect of the
elongation inhibitor 6-azauracil (6-AU) on the growth of the
single mutants (K330R and K695R) was tested. 6-AU
causes a decrease in cellular UTP/GTP levels and thus in-
creases transcriptional arrest (Mason and Struhl [2005]
and references therein). The growth rate of both mutants
was significantly affected by 6-AU, suggesting a role for
the residues in transcript elongation in vivo (Figure 1C).
Moreover, mutation of K330 (but not K695) was lethal in
cells lacking the general elongation factor, TFIIS (encoded
by DST1) (Figure 1D). Together, these data suggest a role
for the ubiquitylatable lysines in transcript elongation.
We next investigated the roles of K330 and K695 in
RNAPII ubiquitylation in vivo. Following treatment with
6-AU to induce RNAPII arrest and Rpb1 ubiquitylation,
the polymerase was immunopurified and subjected to
western blotting, using antiubiquitin antibodies (Figure 1E).
As expected (Somesh et al., 2005), wild-type (wt) RNAPII
became polyubiquitylated under these conditions, but lit-
tle ubiquitylation was detected with RNAPII from K695R
cells, and even less with RNAPII from K330R cells, indicat-
ing that the sites are indeed targets for arrest-induced
RNAPII ubiquitylation.
The RNAPII Ubiquitylation Sites Play a Role
in the Damage Response
RNAPII is ubiquitylated and degraded in response to ultra-
violet (UV) irradiation, and we previously proposed that
this represents an alternative to removal of DNA damage
by transcription-coupled repair (TCR) (Woudstra et al.,
2002; Svejstrup, 2003). Similar to cells lacking RAD26
(encoding the yeast TCR factor homologous to human
Cockayne syndrome B [van Gool et al., 1994]), cells carry-
ing mutations in the RNAPII ubiquitylation sites were not
UV sensitive. In agreement with the proposed model,
however, cells lacking both RAD26 and one of the
RNAPII ubiquitylation sites (especially K330) were highly
UV sensitive (Figure 2A). Moreover, RNAPII ubiquitylation
in response to UV irradiation was dramatically reduced
in the K695R mutant (Figure 2B, compare lanes 2 and 6).
In K330R, ubiquitylation was almost undetectable, with
only a very low level of modification detected in some ex-
periments (Figure 2B, compare lanes 2 and 4; data not
shown).
RNAPII ubiquitylation was previously shown to result in
degradation by the proteasome (Ratner et al., 1998; Beau-
denon et al., 1999). Interestingly, though RNAPII ubiquity-
lation was reduced in K695R, no reduction in the level of
this RNAPII mutant was observed upon UV irradiation. In
contrast, the level of the K330R mutant was dramatically
reduced (Figure 2C, compare Rpb1 levels in lanes 2 and
3, 7 and 8, and 12 and 13). These data correlate with the
UV sensitivity of the mutants observed in the rad26 back-
ground and support the idea that cell viability during DNA
damage in genes relies on an ability to either perform TCR
or degrade RNAPII efficiently so that repair can take place
by other mechanisms (Svejstrup, 2003).
The in vivo observations weremirrored by in vitro exper-
iments performed with recombinant ubiquitylation factorsand highly purified wt or mutant RNAPII (Figure 2D). Only
low levels of ubiquitylation of the mutant polymerases
was detected under conditions that yielded efficient poly-
ubiquitylation of wt RNAPII, and even monoubiquitylation
Figure 2. UV Sensitivity and Reduced RNAPII Ubiquitylation
upon Mutation of the Rpb1 Ubiquitylation Sites
(A) Sensitivity of Rpb1 mutants to UV-irradiation, in the presence or
absence of rad26 mutation. Dilution series were grown on YPD, with
or without prior UV-irradiation (60 J/m2).
(B) Ubiquitylation of Rpb1 in response to UV-irradiation in wt, K330R,
and K695R. See legend of Figure 1E for description.
(C) Degradation of Rpb1 in response to UV (250 J/m2) in WT, K330R,
and K695R. Western blot for RNAPII at different times after UV is
shown. Tubulin (Tub1) serves as loading control.
(D) RNAPII ubiquitylation was reconstituted in vitro using highly purified
factors (Uba1, Ubc5, and Rsp5 [Somesh et al., 2005]) in combination
with his-tagged ubiquitin (left panel) or his-tagged ubiquitin lacking
lysines (mono-ubiquitylation) (right panel), respectively. Ubiquitylation
products were separated by SDS-PAGE and uncovered by probing
Western blots with anti-hexahistidine antibodies (Somesh et al., 2005).Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc. 59
was dramatically reduced (Figure 2D, left and right panel;
data not shown).
Taken together, the data above strongly suggest that
Rpb1-K695 and -K330 are indeed relevant and important
RNAPII ubiquitylation sites. Moreover, the finding that
mutation of either site is sufficient to dramatically reduce
overall RNAPII ubiquitylation both in vivo and in vitro
was intriguing, as it suggests that modification of the
two sites is somehow interdependent.
Placement of the Ubiquitylation Sites
in the RNAPII Structure
The location of the ubiquitylation sites in the RNAPII crys-
tal structure (Figure 7A; see also Figure S6) led to several
conclusions. First, K330 is situated in the so-called switch
2 domain, which is unordered in free RNAPII, but highly or-
dered in the elongating form of the enzyme (Gnatt et al.,
2001). This location may explain the strong preference of
ubiquitylation for the elongating form of RNAPII compared
to the free form, even in vitro (Somesh et al., 2005): a major
target site for the ubiquitylation machinery adopts a con-
formation in this form of the enzyme that allows efficient
modification. Secondly, the sites are located far apart
(about 125 A˚ngstroms), on opposite faces of RNAPII and
far away from the (exit point of the) CTD (Figure 7A), which
is also required for ubiquitylation.
The E3, Rsp5, but Not the E2, Ubc5, Requires theCTD
for Association with RNAPII
We investigated the interdependence of the two distant
ubiquitylation sites and their spatial relationship with the
CTD with the use of our defined ubiquitylation system for
studies in vitro. We surmised that the site interdepen-
dence would best be explained if establishment of a func-
tional ubiquitylation complex on RNAPII requires binding
of the E2 and/or the E3 to the regions around the sites.
In this case, if one of the sites were absent, correct
RNAPII binding by the ubiquitylation factors might be
perturbed and only little ubiquitylation take place. Asmen-
tioned, the CTD of RNAPII is required for ubiquitylation
(Somesh et al., 2005), and the E3, Rsp5, is known to
bind the RNAPII CTD directly (Huibregtse et al., 1997).
Thus, assembly of the ubiquitylation complex might in-
volve interactions with both the CTD and the region
around the ubiquitylation sites.
To first investigate whether Rsp5 or Ubc5 require the
CTD for interaction with RNAPII, we used immobilized
RNAPII-HA, or immobilized RNAPII lacking the CTD
(RNAPIIDCTD-HA; Li and Kornberg [1994]; Somesh et al.
[2005]) and incubated them with either recombinant
GST-Rsp5 or GST-Ubc5 (Figure 3). GST-Rsp5 bound
well to immobilized RNAPII containing the CTD but failed
to interact with CTD-less RNAPII (Figure 3A). Likewise,
CTD-containing, but not CTD-less, RNAPII bound immo-
bilized GST-Rsp5 (Figure S2). In contrast, GST-Ubc5
bound to both RNAPII and RNAPIIDCTD (Figure 3B).
Our previous data showed that RNAPII ubiquitylation
is inhibited by serine 5 phosphorylation both in vivo and60 Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc.in vitro (Somesh et al., 2005). Rsp5-RNAPII binding ex-
periments with purified proteins uncovered the likely
mechanistic basis for this, as Rsp5 failed to bind serine
5-phosphorylated RNAPII (Figure 3C, compare lanes 2
and 4).
Ubc5 Binds to the RNAPII Ubiquitylation Sites
As Ubc5 binds RNAPII in a CTD-independent manner, we
investigated binding of this protein to RNAPII carrying
point mutations in the Rpb1 ubiquitylation sites. GST-
Ubc5 was immobilized on glutathione beads (with GST
alone as control), and incubated with wt or mutated forms
of RNAPII (Figure 3D). Strikingly, whereas wt RNAPII
bound efficiently to beads containing Ubc5, binding of
K695R-RNAPII was slightly, but reproducibly, reduced,
and binding of RNAPII-K330R was dramatically reduced
(compare lanes 5–7, 11–13, and 17–19).
To investigate if residual (weak) binding of Ubc5 to K695
still occurred in the RNAPII-K330R mutant and if a detect-
able reduction in binding could be observed in the RNAPII-
K695R mutant, wt and mutant RNAPIIs were now im-
mobilized via their CTD, and incubated with GST-Ubc5
(Figure 3E). Using this experimental approach, we consis-
tently observed reduced binding of Ubc5 to RNAPII-
K695R (Figure 3E, compare lanes 10–12 with 4–6). It
was also clear that RNAPII-K330R retains some capacity
for binding Ubc5 (Figure 3E, compare lanes 7–9 with 4–6
and 1–3 [control]).
As expected, point mutation of the Rpb1 ubiquitylation
sites had no effect on the RNAPII binding of Rsp5 (data
not shown).
Together, these data indicate that Ubc5, but not Rsp5,
recognizes and binds the actual sites of modification in
RNAPII.
Ubiquitylation of RNAPII Requires the Active Sites
of Both Ubc5 and Rsp5
The finding that Ubc5 rather than Rsp5 recognizes the
RNAPII ubiquitylation sites was surprising because E2s
are generally not believed to be involved in target recogni-
tion. In ubiquitylation by HECT family ubiquitin ligases (to
which Rsp5 belongs), ubiquitin is transferred from the ac-
tive site of the E2 to that of the E3, and then to the target. It
was therefore relevant to test whether ubiquitin transfer
might occur directly from Ubc5 to the polymerase, rather
than via Rsp5’s active site. If Rsp5 were merely serving
a structural role, it might thus be expected that a point
mutation in its active site would have no effect on ubiqui-
tylation. As can be seen in Figure 3F, however, the active
sites of Rsp5 and Ubc5 were both absolutely required for
RNAPII ubiquitylation. This suggests that an Ubc5-Rsp5-
substrate complex is established at the ubiquitylation
sites, in which ubiquitin is transferred from E2 to E3 to sub-
strate, as is normally observed with HECT E3 ligases.
Evidence for a Multimeric E2/E3 Complex
The interdependence of the ubiquitylation sites, the fact
that Rsp5 binds RNAPII via the highly repeated C-terminal
Figure 3. Rsp5 and Ubc5 Associate with RNAPII in a CTD-Dependent and an Ubiquitylation-Site-Dependent Manner, Respectively
(A) GST-Rsp5 was incubated with immobilized HA-tagged RNAPII or immobilized HA-tagged RNAPII lacking the CTD (RNAPII-DCTD). Shown in the
lower panel is a western blot of 12CA5 (anti-HA) associated protein, probed with anti-Rsp5 antibodies. Shown in the upper panel is the Ponceau S
stain of the western blot membrane.
(B) As in (A), but with GST-Ubc5.
(C) Immobilized GST, or GST-Rsp5, was incubated with RNAPII (RNAPIIA), or serine 5-phosphorylated RNAPII (RNAPII0-Ser5), respectively. Proteins
were resolved by 10%SDS-PAGE, and western blot of bound Rpb1 was probed with 4H8 (lanes 1 and 2) and anti-Ser5 (H14) (lanes 3 and 4) antibody,
respectively.
(D) Immobilized GST (lanes 2–4, 8–10, and 14–16) or GST-Ubc5 (lanes 5–7, 11–13, and 17–19) was incubated with varying amounts (0.3, 0.6, and
0.9 mg) of the different forms of RNAPII indicated on top. Shown in the upper panel is a western blot of bound protein, probed with anti-Rpb1
(4H8) antibodies. Shown in the lower panel is a Ponceau S stain of the membrane showing GST and GST-Ubc5 used in the different experiments.
(E) Immobilized RNAPII (0.3 mg of version indicated on top) was incubated with varying amounts (0.3, 0.6, and 1 mg) of GST-Ubc5. Shown in the
upper panel is a western blot of bound protein, probed with anti-GST antibodies. Shown in the lower panel is a Ponceau S stain of the membrane
showing immobilized RNAPII. Please note that less stringent conditions were used in these experiments than in (D).
(F) RNAPII ubiquitylation in vitro using wt and point-mutated active site versions of Rsp5 (left panel) and Ubc5 (right panel), respectively.domain (CTD), and the finding above that pointmutation of
either ubiquitylation site affects Ubc5 binding could be ex-
plained if modification occurs in a multimeric E2/E3 com-
plex, capable of accessing two sites. This prompted us to
investigate how many molecules of Rsp5 and Ubc5 bindto RNAPII (Figure 4). This was done by two approaches.
First, we titrated increasing amounts of Rsp5 into an
RNAPII binding reaction. Scanning of the resulting
Coomassie-stained gels suggested that RNAPII binding
reached a plateau at two molecules of Rsp5 (Figure S3).Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc. 61
In a second approach, increasing amounts of untagged
Rsp5 were titrated into a binding reaction containing
a constant amount of GST-Rsp5 and RNAPII. Associated
proteins were then isolated on glutathione-sepharose
beads via the tag on GST-Rsp5 and the beads examined
for the presence of untagged Rsp5 (Figure 4A). Untagged
Rsp5 only associated with GST-Rsp5 in the presence of
RNAPII (Figure 4A, compare lane 1 with lanes 2–5), in
agreement with the notion that Rsp5 otherwise behaves
as a monomeric protein (data not shown) and indicating
that the dimerization sometimes observed with GST-
tagged proteins was not a problem in these experiments.
Significantly, upon addition of increasing amounts of Rsp5
protein, the level of bound, untagged Rsp5 reached a pla-
teau at a level similar to that of GST-Rsp5, as expected if
two molecules of Rsp5 concomitantly bind RNAPII.
Figure 4. Two Molecules of Rsp5 Associate with RNAPII
(A) GST-Rsp5 was incubated with increasing amounts of untagged
Rsp5 in the presence, or absence, of a 2-fold excess of RNAPII. Shown
in the upper panel is a schematic representation of the experimental
approach. Shown in the lower panel is a Coomassie-stained gel show-
ing resin-associated proteins. Proteins added are indicated above.
The numbers indicate the amount of untaggedRsp5 added (molar ratio
relative to GST-Rsp5).
(B) As in (A), but using GST-Ubc5 and Ubc5.62 Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc.The same experimental approach was taken to investi-
gate if more than one copy of Ubc5 bind RNAPII (Figure 4B
and data not shown). Untagged Ubc5 bound immobilized
GST-Ubc5 in an RNAPII-dependent manner, and the
amounts of protein bound indicated that at least two
Ubc5 molecules bind RNAPII (Figure 4B, compare GST-
Ubc5 and Ubc5 in lanes 4 and 5).
The Role of the CTD in the Establishment
of a Functional Ubiquitylation Complex
The above experiments support a model in which Ubc5
molecules bind RNAPII at the sites of ubiquitylation and
then allow the recruitment of two copies of CTD bound
Rsp5 to trigger site-specific ubiquitylation. The CTD and
its linker are presumed to be highly flexible and can, in
an extended state, span hundreds of A˚ngstroms from
base to tip. The CTD might, however, alternatively be or-
dered in a discrete fold that makes the effective length
much shorter (reviewed by Meinhart et al. [2005]). Indeed,
yeast cells with 10–12 CTD repeats (rather than the normal
26) are only conditionally viable, and a minimum of 10 re-
peats are required for viability (Nonet et al., 1987). The dis-
tance from the last ordered residue at the base of the CTD
linker across the surface of RNAPII to Rpb1 lysine 695 is
more than 175 A˚ngstroms (refer to Figure 7A). In light of
the above results it was therefore interesting to investigate
if a shorter CTD is capable of supporting RNAPII ubiquity-
lation. RNAPII with 12 CTD repeats (Nonet et al., 1987)
was therefore purified (Figure 5A) and tested in the ubiqui-
tylation assay. Strikingly, ubiquitylation of RNAPII-12 was
dramatically reduced (Figure 5B). Binding experiments
showed that RNAPII-12 could still associate with Rsp5,
although clearly less efficiently (Figure 5C and data not
shown), opening the possibility that the binding of Rsp5
to RNAPII is cooperative. These data indicate a CTD
length requirement for a productive RNAPII ubiquitylation
complex to form.
Formation of a Functional Ubiquitylation Complex
Requires Ubc5 Binding to the Region
around the Ubiquitylation Sites
The results above support the idea that two molecules of
Rsp5 associate with the CTD to organize a complex capa-
ble of ubiquitylating RNAPII via interaction with Ubc5
molecules bound to the regions surrounding the sites.
To further experimentally explore this model, we first in-
vestigated whether Ubc5 and Rsp5 directly interact. This
was indeed the case (Figures 6A and S4).
We next performed gel migration-retardation experi-
ments with preformed RNAPII elongation complexes (Fig-
ures 6B and 6C). Addition of the Ubc5 protein alone did
not radically affect the migration of the RNAPII/DNA/
RNA ternary complex (Figures 6B [lanes 1 and 2] and 6C
[labeled ‘‘tern.’’]). Addition of Rsp5, however, retarded
migration dramatically, leading to an extended smear of
more slowly migrating RNAPII elongation complexes (Fig-
ures 6B [lane 3] and 6C [labeled ‘‘tern.’’]). The reason for
the dramatic difference in mobility between complexes
containing Ubc5 andRsp5 is unknown butmight be due to
their size difference (16 kDa versus 92 kDa) or, more likely,
that Ubc5 binds the body of the polymerase, while Rsp5
binds the flexible CTD.
Significantly, addition of Ubc5 to the RNAPII-Rsp5 com-
plex increased, rather than further decreased, complex
mobility, leading to a much better defined band in the
gel. (Figure 6B, lane 4 and labeled with asterisk). Antibody
super-shift experiments showed that both Rsp5 and Ubc5
were indeed present in this complex (Figure 6B, compare
lanes 5 and 6with lane 4). These data support the idea that
the Rsp5-associated, flexible CTD exists in a number of
different structural conformations but that, as a conse-
quence of Ubc5-Rsp5 association, it becomes ordered
across the surface of RNAPII. In agreement with the
flexible CTD contributing significantly to the gel mobility
of RNAPII elongation complexes, RNAPII-12 and
RNAPIIDCTD indeed migrated faster than wt complexes
(Figure 6B, compare lanes 7, 9, and 11). As expected,
only the mobility of the polymerase complexes lacking
the CTD remained unchanged upon addition of Rsp5
(Figure 6B, lane 12), showing that the Rsp5-mediated
mobility shift of wt (lane 8) and CTD-12 (lane 10) RNAPII
complexes was due to Rsp5-CTD interactions.
The experiments of Figure 3D showed that RNAPII with
mutated ubiquitylation sites (in particular K330R) is unable
Figure 5. RNAPII with a Shorter CTD Cannot Be Ubiquitylated
or Associate Efficiently with Rsp5
(A) Coomassie-stained gel showing RNAPII and RNAPII-12.
(B) Ubiquitylation of RNAPII-12. For technical reasons, monoubiquity-
lation (using ubiquitin lacking lysines) was compared in this experi-
ment, but polyubiquitylation was also dramatically decreased (data
not shown).
(C) An excess of GST-Rsp5 was incubated with similar amounts of
RNAPII and RNAPII-12 (see A), respectively, and resin-associated pro-
teins resolved on SDS-PAGE after washing. A Coomassie-stained gel
is shown.to associate with immobilized Ubc5 in a stable manner.
If Ubc5 orders the Rsp5-CTD complex on the surface of
RNAPII, then this might not occur with mutated ubiquityla-
tion sites. The mobility shift caused by Ubc5/Rsp5 addi-
tion was therefore investigated using the RNAPII ubiquity-
lation-site mutants (Figure 6C). Under conditions that led
to a clear increase in the mobility of wt RNAPII-Rsp5 com-
plexes upon Ubc5 addition, little or no mobility shift of the
K330R mutant complex was observed (Figure 6C, com-
pare lanes 3 and 4 with lanes 7 and 8). Mobility of the
RNAPII-Rsp5 complex carrying the Rpb1-K695R muta-
tion was slightly affected by Ubc5 addition, but not to
the extent observed with wt RNAPII (Figure 6C, compare
lanes 3 and 4 with lanes 11 and 12; relevant complex des-
ignated on right-hand side by asterisk). These results
strongly support the idea that Ubc5 binds the Rpb1
ubiquitylation sites and thereby positions the (CTD-asso-
ciated) Rsp5 molecules correctly, so that site-specific
ubiquitylation can take place.
DISCUSSION
The results reported here provide novel information on
several levels. First, two ubiquitylation sites in the largest
subunit of yeast RNAPII, K330, and K695, have been iden-
tified. Mutation of these sites gives rise to elongation phe-
notypes and defects in the DNA-damage response, and
RNAPII ubiquitylation in vivo and in vitro is perturbed. Sec-
ondly, the data detail themolecular mechanism underlying
RNAPII ubiquitylation by Rsp5 and Ubc5. Two copies of
each bind RNAPII to couple distant ubiquitylation events.
Thirdly, our data challenge the generally accepted view
that E3s alone recognize the protein substrates. The E2,
Ubc5, binds directly to RNAPII, and this binding is per-
turbed if one of the ubiquitylation sites is mutated. Finally,
the results are informative about the structure and function
of the RNAPII CTD. Together, the data give unprece-
dented insight into the biochemical mechanism underlying
RNAPII ubiquitylation and provide a new paradigm for
understanding protein ubiquitylation by HECT ubiquitin
ligases.
RNAPII Ubiquitylation Sites
The data presented here show that the Rpb1 ubiquityla-
tion sites mapped in vitro using pure ubiquitylation factors
are also important for transcriptional elongation, the DNA-
damage response, and RNAPII ubiquitylation in response
to transcriptional arrest in vivo. For example, mutation of
K330 in combination with mutation of Rad26 (required
for TCR) gives rise to a dramatic increase in yeast UV sen-
sitivity. Such a dramatic increase is not seen with the K695
mutation (which, in contrast to K330R, has little effect on
RNAPII degradation). We previously suggested that ubiq-
uitylation/degradation of RNAPII represents an important
alternative to DNA repair by TCR (Woudstra et al., 2002;
Svejstrup, 2003), so these results provide strong evidence
in support for this model.Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc. 63
Figure 6. Ubc5 Orders the CTD-Associated Rsp5 Molecules across RNAPII
(A) GST or GST-Ubc5 was incubated with Rsp5, and resin-associated proteins resolved on SDS-PAGE. A Coomassie-stained gel is shown.
(B) Gel mobility of an RNAPII elongation complex in the absence or presence of Ubc5, Rsp5, or both. Added factors are indicated above. In lanes 5 and
6 is gel mobility of RNAPII-Rsp5-Ubc5 elongation complexes upon addition of anti-Rsp5 (lane 5) or anti-Ubc5 (lane 6) antibody. In lanes 7–12 is gel
mobility of RNAPII elongation complexes that have different lengths of CTD, in the absence or presence of Rsp5 as indicated. To save space, the
bottom of the gel (free RNA) was been omitted.
(C) Gel mobility of wt and mutant RNAPII elongation complexes in the absence or presence of Ubc5, Rsp5, or both. Migration and content of com-
plexes resulting from factor addition are indicated next to lanes. Figure S5 shows a version of Figure 6B with the identity of the different complexes
schematically indicated.The results from a combination of in vivo and in vitro ex-
periments suggest that Rpb1 ubiquitylation is likely have
evolved as more than simply a mechanism to allow degra-
dation of the polymerase. Indeed, given that Rsp5 binds
RNAPII via the CTD (Huibregtse et al., 1997; Somesh
et al., 2005), it might have been expected that any one
of the numerous surface-exposed lysines in Rpb1/RNAPII
would be a potential target and that there would simply be
‘‘preferred’’ sites for ubiquitylation on the path to polymer-
ase degradation. However, this is clearly not the case.
Very specific sites are targeted, and without these sites,
little RNAPII ubiquitylation takes place, with conse-
quences for transcription and the DNA-damage response.
This could indicate that the actual location of the ubiquity-
lation sites is of functional importance.
Interestingly, whereas the single K330R and K695Rmu-
tations did not give rise to discernable growth phenotypes
on rich media, mutation of both sites was lethal. In view of64 Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc.the fact that K330R mutation in itself is sufficient to result
in significant abrogation of RNAPII ubiquitylation and deg-
radation in vivo (but has no growth phenotype), this sup-
ports the idea that the sitesmay perform both overlapping,
and nonoverlapping, roles in RNAPII biology. It is addition-
ally possible, however, that a low level of ubiquitylation/
degradation through K695 still persists in the K330R
mutant in vivo. This might be sufficient for survival under
normal conditions (i.e., to remove the low basal level of
irreversibly stalled RNAPII), but not during transcriptional
stress, such as that encountered during DNA damage in
the absence of Rad26. Experiments aimed at elucidating
potential differences between the ubiquitylation sites are
presently in progress.
A complex relationship between RNAPII ubiquitylation
and degradation was underscored by the finding that al-
though K695Rmutation led to a dramatic decrease in de-
tectable RNAPII polyubiquitylation, the mutation had little
effect on UV-induced RNAPII degradation. Although other
possibilities cannot be ruled out, this might be explained if
proteolysis, rather than ubiquitylation, is rate limiting under
the conditions required to detect degradation (i.e., a high
dose of UV irradiation, where a generally elevated level
of proteasomal activity is needed for cell survival), so
that though the rate of RNAPII ubiquitylation is reduced
in the absence of K695, this does not significantly affect
RNAPII degradation during the first few hours after UV
irradiation.
The Locations of the RNAPII Ubiquitylation Sites
Placement of the ubiquitylation sites in the RNAPII struc-
ture shows that they are very far from each other and
from the exit point of the functionally important CTD (Fig-
ure 7A). It also supports the idea that the location of the
ubiquitylation sites is functionally relevant.
Changes in the RNAPII protein structure between the
transcribing complex and the free enzyme include closure
of a clamp over the DNA and RNA and ordering of a series
of ‘‘switches’’ in the clamp to create a binding site comple-
mentary to the DNA-RNA hybrid (Gnatt et al., 2001). K330
is located in one of these switches (switch 2) (Figures 7A
and S6A). The structural ordering of switch 2 may explain
why simply incorporating RNAPII into a ternary RNAPII/
DNA/RNA complex in vitro makes it a much better sub-
strate than the free enzyme. Indeed, Ubc5 prefers binding
the elongating RNAPII form in vitro (Figure S7). This is of
obvious relevance for the situation in cells where, besides
the importance of the RNAPII phosphorylation state
(Somesh et al., 2005), the structural conformation of the
polymerase might add specificity to the ubiquitylation
reaction, so that the elongating form is preferentially
targeted. Interestingly, ubiquitin transfer to such a func-
tionally important domain, relatively close to the RNAPII
active site, might also be expected to affect transcription
ability, or fidelity, as RNAPII arrests. This is presently un-
der investigation.
The other ubiquitylation site, K695, is situated imme-
diately below the Rpb9 subunit in the RNAPII structure
(Figures 7A and S6B). This opens the possibility that
Rpb9, important for transcript elongation and transcrip-
tion-coupled repair (Hemming et al., 2000; Li and Smer-
don, 2002), also plays a role in RNAPII ubiquitylation.
Indeed, we have found that ubiquitylation is perturbed in
RNAPII lacking the Rpb9 subunit (B.S. and J.Q.S., unpub-
lished data).
The Mechanism of RNAPII Ubiquitylation
The results reported here make it possible to propose
a detailed model for the mechanism of RNAPII ubiquityla-
tion by Ubc5 (E2) and Rsp5 (E3) (Figure 7B). This model
and the experiments that led to it were guided and also
given credence by the RNAPII crystal structures (Cramer
et al., 2001; Gnatt et al., 2001; Westover et al., 2004).
Our results indicate that two E2/E3 complexes form on
RNAPII, enabling the two distant ubiquitylation events to
take place (Figure 7B, left panel). In the absence of justone of the RNAPII ubiquitylation sites, correct assembly
of these connected complexes is perturbed, and little
ubiquitylation takes place, suggesting that a conforma-
tional effect is transmitted through the chain of protein-
protein interactions from one site to the other. Alter-
natively, the effect of site mutation might be due entirely
to decreased binding affinity when one site, rather than
two, is present. According to this model, the two Rsp5
molecules need to be precisely aligned with the substrate
lysines, via the association of Rsp5 with Ubc5 (bound at
the target sites) so that ubiquitin can be correctly trans-
ferred from E2 to E3 to these target sites. In the absence
of K330, the weak binding of Ubc5 at K695 is insufficient
to lead to Rsp5 association (and CTD ordering) (Figure 7B,
right panel). Therefore, very little ubiquitylation is possible.
In the absence of K695, some association of Rsp5 via
K330 bound Ubc5 is observed, but the Ubc5-Rsp5-
substrate complex formed is suboptimal, leading to re-
duced ubiquitylation efficiency (Figure 7B, bottom panel).
Whether Rsp5 forms an actual dimer in which the mono-
mers functionally interact or whether the CTD provides
the only connection between the Rsp5 molecules remains
to be resolved.
The fact that mutation of either one of the two sites is
sufficient to dramatically reduce RNAPII ubiquitylation in-
dicates that binding of Ubc5 to the ubiquitylation sites is
crucial for activity. The structural difference between
lysine and arginine (the change made in the mutants) is
small, though the protonation state of the domains in
question might be altered as a result of the change. It is
thus possible that the failure to ubiquitylate is due to an in-
crease in the binding dissociation constant upon site mu-
tation. If so, it might be expected that normal ubiquityla-
tion of RNAPII in vitro would be recovered by adding
more Ubc5. Indeed, preliminary experiments indicate
that addition of a 2- to 4-fold excess of ubiquitylation pro-
teins makes it possible to detect ubiquitylation in mutant
RNAPII (data not shown).
Implications for Protein Ubiquitylation Models
It is generally accepted that E3s are responsible for sub-
strate recognition, whereas E2s either hand over ubiquitin
to the E3 (HECT E3s) or directly ubiquitylate the substrate
after associating with substrate bound E3 (ring E3s) (Pick-
art, 2001; Ardley and Robinson, 2005). However, in the
case presented here, it is the E2, which directly recognizes
the ubiquitylation sites. Indeed, one of the sites, K330, is
bound so strongly that it is required for association of
RNAPII with immobilized Ubc5 under certain conditions.
Interestingly, although sequence-specific protein recogni-
tion of a modification site by an E2 has not to our knowl-
edge previously been reported for protein ubiquitylation,
the E2 dedicated to protein sumoylation, Ubc9, recog-
nizes a c-K-x-D/E motif (where c is a hydrophobic residue
and x is any amino acid) (Bernier-Villamor et al., 2002).
Neither of the RNAPII ubiquitylation sites conforms to
this consensus. Moreover, alignment of the sequences
surrounding K330 and K695, respectively, shows noCell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc. 65
Figure 7. Placement of the Ubiquitylation Sites in the RNAPII Structure and a Model for the Mechanism of RNAPII Ubiquitylation
(A) In the left panel is a ribbon diagramof the RNAPII crystal structure (Westover et al., 2004) viewed from abovewith the DNA (green) andRNAproduct
(magenta), as well as the path of the DNA template (yellow cylinder, arrow showing direction of transcription) indicated. Ubiquitylation sites and the
CTD exit point are indicated as colored spheres. Note that in this view the ubiquitylation sites are partly hidden by protein density. In the right panel is
a front view of the RNAPII structure. Here, the ubiquitylation site lysines (in red) are indicated with their side chains. An expanded view of K330 and
K695 is provided in Figure S6.
(B) A model for the mechanism of RNAPII ubiquitylation. As shown in the left panel, with wt RNAPII, Ubc5 can bind the body of the polymerase around
the ubiquitylation sites, and twomolecules of Rsp5 bind the CTD. These are brought to the sites of ubiquitylation (thereby ordering the CTD across the
surface of RNAPII) by the Rsp5-Ubc5 interaction. As shown in the right panel, in the absence of K330, Ubc5 binding to that site is reduced, and the
correct placement of (both) CTD bound Rsp5 is hindered. No ubiquitylation takes place. As shown in the lower panel, in the absence of K695, Ubc5
binding to that site is reduced, and although some association at K330 still takes place, a fully functional Ubc5-Rsp5-substrate complex is not formed.
Only little ubiquitylation therefore takes place. Red circles indicate ubiquitylation sites. Gray circles indicate mutated ubiquitylation sites.66 Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc.
conserved amino acids (except for the lysines), and there
is no recognizable degenerate recognition motif or ob-
vious structural similarity between the regions. Thus,
although the site specificity of the ubiquitylation system
is unmistakeable and observed both in vivo and in vitro,
further studies are required to uncover the structural basis
for RNAPII substrate-sequence recognition by Ubc5.
A recent model on ubiquitin transfer by HECT ubiquitin
ligases (based on structural work on the Rsp5 homolog,
WWP1 [Verdecia et al., 2003]) proposes that transfer of
ubiquitin from the active site of the E2 to that of the E3 is
followed by a dramatic conformational change in the E3
around a flexible hinge connecting the active site lobe
and the E2 binding lobe, allowing the E3 active site to
‘‘swing away’’ from the E2 to transfer ubiquitin to the
substrate. It is implicit in this model that the E2 is at a con-
siderable distance from the site of modification on the
substrate, which does not appear to be the case in the sit-
uation presented here. The structural details of ubiquitin
transfer by HECT ligases remains an important open
question.
The Role of the CTD
The function of the CTD of RNAPII has been the subject of
immense interest over the last decade. It is clear from
numerous studies that the CTD plays a pivotal role in
just about all transcription reactions, via its (often phos-
phorylation-dependent) interactions with distinct proteins
(Kobor and Greenblatt, 2002; Meinhart et al., 2005). In the
crystal structure, the absence of electron density owing to
the linker and CTD provides evidence of motion or disor-
der, but even if disordered, the CTD is unlikely to be in
a completely extended conformation. Indeed, the linker
and CTD regions of four neighboring RNAPII molecules
share a space in the crystal that can only accommodate
them in a fairly compact conformation (Cramer et al.,
2001). This does not rule out the possibility that the CTD
adopts different conformations and positions depending
on the circumstances, but the position of the CTD relative
to the body of the polymerase during the different steps of
the transcription cycle has so far only been the subject of
speculation (Meinhart et al., 2005). Our data indicate that
a full-length CTD (26 repeats), but not a 12-repeat CTD, al-
low the assembly of an E3 dimer, which is then brought
into contact with the sites of ubiquitylation through inter-
action with the E2. The position of the ubiquitylation sites
and the CTD in the crystal structure, the inability of a short-
ened CTD to support ubiquitylation, and the gel mobility of
the E2/E3-associated RNAPII elongation complex, to-
gether suggest that the CTD becomes ordered across
the body of RNAPII, and outline the direction it follows
from its base on one side and across at least 175 A˚ng-
stroms to the other side of the molecule during RNAPII
ubiquitylation (Figure 7). The data presented here thus
also provide a rare glimpse into the structural flexibility af-
forded by the CTD and afford a conceptual framework on
which to build structural models for other CTD-dependent
molecular processes.EXPERIMENTAL PROCEDURES
Yeast Strains and Expression Plasmids
Strains for genetic experiments were congenic with W303, and some
were described previously (Somesh et al., 2005). Other strains and
bacterial expression plasmids used (source) were RPB1-C6 CTD
(Richard Young, Whitehead Institute), YF2277 (Jim Friesen, University
of Toronto), GST-Rsp5/GST-Rsp5 C777A (Jon Huibregtse, Univer-
sity of Texas), GST-Ubc5/GST-Ubc5 C85A (Aaron Ciechanover,
Technion-Israel Institute of Technology), and GST-CTD (Nick Proud-
foot, University of Oxford).
Site-Directed Mutagenesis and Yeast Manipulation
Site-directed mutagenesis was performed on a plasmid containing
a fragment of the RPB1 gene using the QuikChange II XL mutagenesis
kit (Stratagene, La Jolla, CA). Oligonucleotide sequences are available
on request. To generate yeast strains expressing single-, double-, or
triple-mutated Rpb1, mutated RPB1 fragments were inserted in place
of the wt fragment in RPB1 carried on a TRP1 CEN plasmid. These
plasmids were transformed into YF2277 (containing wt RPB1 on
a URA3 CEN plasmid [Archambault et al., 1998]). Cells expressing
only mutated Rpb1 (or wt control) from the TRP1 plasmid were se-
lected on 5-fluoroorotic acid (5-FOA)-containing media, evicting the
URA3 marker. For similar experiments with dst1 rpb1 and rad26
rpb1 strains, DST1 or RAD26, respectively, was replaced with the
HIS3marker in YF2277. rad26 rpb1 strains were tested for UV sensitiv-
ity by irradiation (60 J/m2) in a UV Stratalinker 2400 (Stratagene,
La Jolla, CA). Plates were incubated for 3–4 days at 30C.
For 6-AU sensitivity assays, strains weremadeURA+ by transforma-
tion with pRS316 and grown on synthetic complete medium plates
lacking uracil (SCuracil), or SCuracil plates containing 6-AU
(50 mg/ml).
Proteins, In Vitro Ubiquitylation, and Mapping of Ubiquitylation
Site of Rpb1
His-tagged ubiquitin, yeast GST-Uba1, GST-Ubc5, GST-Rsp5,
RNAPII, and CTD-less RNAPII were obtained/purified as previously
described (Somesh et al., 2005). His-tagged ubiquitin lacking lysines
(for monoubiquitylation) was obtained from Boston Biochemical.
GST-less Rsp5 was generated by cleaving GST-Rsp5 with PreSci-
ssion Protease (Amersham Biosciences) in 50 mM Tris-HCl, 150 mM
NaCl, 1 mMEDTA, 1mMDTT (pH 7.0) for 16 hr at 4C. Free GST/uncut
GST-Rsp5 was removed using glutathione sepharose. GST-CTD was
purified as described for purification of other GST-tagged proteins
(Somesh et al., 2005). In vitro ubiquitylation of RNAPII and mapping
of ubiquitylation sites was done as described (Somesh et al., 2005).
Assembly of RNAPII Ternary Complexes and Gel Mobility
Shift Assays
RNAPII ternary complexes were assembled from oligonucleotides as
described (Somesh et al., 2005). The RNA oligonucleotide was end la-
beled using T4 polynucleotide kinase (New England Biolabs). Ternary
complexes were resolved by 0.7% agarose gel electrophoresis for 12–
14 hr at 4C, followed by autoradiography.
Immunoprecipitation of Ubiquitylated RNAPII
The effect on ubiquitylation and Rpb1 degradation of 6-AU or UV irra-
diation in vivo was tested as described (Somesh et al., 2005).
Binding Experiments
Purified glutathione-s-transferase (GST), GST-Rsp5, or GST-Ubc5
was incubated for 60 min with glutathione sepharose (Pharmacia) in
buffer (10% glycerol, 0.5% Triton X-100 in phosphate-buffered saline).
Beads were washed and incubated for 2–3 hr with RNAPII (and/or
untagged Rsp5) in incubation buffer (50 mM Tris-Cl, pH 7.5, 300 mM
KOAc, 0.5% Triton X-100, 10% glycerol) with constant mixing. For ex-
periments in which RNAPII was immobilized via the CTD (to 4H8Cell 129, 57–68, April 6, 2007 ª2007 Elsevier Inc. 67
beads) (Figure 3E), only 200 mM KOAc was used in the incubation
buffer). After incubation, beads were washed three times with incuba-
tion buffer and boiled in sodium dodecyl sulphate (SDS) sample buffer.
Bound proteins were analyzed by SDS-PAGE, followed by Coomassie
staining, Ponceau S staining, or western blotting, as indicated. In ex-
periments assessing the binding of Rsp5 and Ubc5 to CTD-less
RNAPII, RNAPII was immobilized on 12CA5-protein A resin. Beads
were then incubated for 2–3 hr with GST-Rsp5 or GST-Ubc5 as above.
Beads were washed as above and bound proteins analyzed by
SDS-PAGE, followed by Ponceau S staining and western blotting.
For testing binding of serine 5-phosphorylated RNAPII to immobilized
GST-Rsp5, RNAPII was phosphorylated by transcription factor II K as
described (Somesh et al., 2005).
Supplemental Data
Supplemental Data include seven figures and can be found with this
article online at http://www.cell.com/cgi/content/full/129/1/57/DC1/.
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